Eight weeks after cancer cell injection and just before the start of treatment, all mice underwent a baseline ITT using the same dose of insulin they received 8 weeks earlier and all mice displayed marked resistance to a decrease in blood glucose following the insulin injection (Figure S1C). Here, INS is linked to cancer.